Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502.

Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502. J Clin Oncol. 2015 Dec 10; 33(35):4167-75.

View in: PubMed

subject areas

Aged
Antineoplastic Combined Chemotherapy Protocols
Busulfan
Disease-Free Survival
Drug Administration Schedule
Female
Graft vs Host Disease
Hematopoietic Stem Cell Transplantation
Humans
Immunosuppressive Agents
Leukemia, Myeloid, Acute
Male
Methotrexate
Middle Aged
Neoplasm Recurrence, Local
Prospective Studies
Remission Induction
Tacrolimus
Transplantation Conditioning
Transplantation, Homologous
Treatment Outcome
Unrelated Donors
Vidarabine

authors with profiles

RICHARD E CHAMPLIN